- Home
- AEHL vs ACXP Comparison
AEHL vs ACXP Comparison
Compare AEHL & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- ACXP
- Stock Information
- Founded
- AEHL 1993
- ACXP 2017
- Country
- AEHL China
- ACXP United States
- Employees
- AEHL N/A
- ACXP N/A
- Industry
- AEHL Building Materials
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- AEHL Industrials
- ACXP Health Care
- Exchange
- AEHL Nasdaq
- ACXP Nasdaq
- Market Cap
- AEHL 8.5M
- ACXP 8.4M
- IPO Year
- AEHL 2007
- ACXP 2021
- Fundamental
- Price
- AEHL $2.75
- ACXP $0.53
- Analyst Decision
- AEHL
- ACXP Strong Buy
- Analyst Count
- AEHL 0
- ACXP 2
- Target Price
- AEHL N/A
- ACXP $10.00
- AVG Volume (30 Days)
- AEHL 123.4K
- ACXP 18.5M
- Earning Date
- AEHL 05-01-2025
- ACXP 08-08-2025
- Dividend Yield
- AEHL N/A
- ACXP N/A
- EPS Growth
- AEHL N/A
- ACXP N/A
- EPS
- AEHL N/A
- ACXP N/A
- Revenue
- AEHL $98,773,000.00
- ACXP N/A
- Revenue This Year
- AEHL N/A
- ACXP N/A
- Revenue Next Year
- AEHL N/A
- ACXP N/A
- P/E Ratio
- AEHL N/A
- ACXP N/A
- Revenue Growth
- AEHL 36.99
- ACXP N/A
- 52 Week Low
- AEHL $1.79
- ACXP $0.30
- 52 Week High
- AEHL $256.40
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- AEHL 53.14
- ACXP 47.99
- Support Level
- AEHL $2.33
- ACXP $0.52
- Resistance Level
- AEHL $2.75
- ACXP $0.63
- Average True Range (ATR)
- AEHL 0.25
- ACXP 0.09
- MACD
- AEHL 0.05
- ACXP 0.00
- Stochastic Oscillator
- AEHL 69.70
- ACXP 17.33
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.